These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 7201801
1. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Kazda S, Garthoff B, Krause HP, Schlossmann K. Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801 [Abstract] [Full Text] [Related]
2. Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity. Kazda S. Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():70-3. PubMed ID: 4010868 [Abstract] [Full Text] [Related]
4. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Kazda S, Towart R. Acta Neurochir (Wien); 1982 Apr; 63(1-4):259-65. PubMed ID: 7102417 [Abstract] [Full Text] [Related]
6. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog. Satoh K, Kawada M, Wada Y, Taira N. Arzneimittelforschung; 1984 Apr; 34(5):563-8. PubMed ID: 6540573 [Abstract] [Full Text] [Related]
7. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats. Tanaka K, Gotoh F, Muramatsu F, Fukuuchi Y, Okayasu H, Suzuki N, Kobari M. Arzneimittelforschung; 1982 Apr; 32(12):1529-34. PubMed ID: 6891592 [Abstract] [Full Text] [Related]
11. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure. Gaab MR, Haubitz I, Brawanski A, Korn A, Czech T. Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872 [Abstract] [Full Text] [Related]
12. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]. Govoni S, Trabucchi M, Battaini F, Magnoni MS, Paoletti R. Minerva Med; 1986 Jun 08; 77(24):1053-8. PubMed ID: 3725133 [Abstract] [Full Text] [Related]
13. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage]. Aleksandrin VV, Khaĭlov NA, Mirzoian GR, Gan'shina TS. Eksp Klin Farmakol; 2002 Jun 08; 65(2):17-9. PubMed ID: 12109284 [Abstract] [Full Text] [Related]
15. Effects of nimodipine on cerebral blood flow in conscious rat. Kanda K, Flaim SF. J Pharmacol Exp Ther; 1986 Jan 08; 236(1):41-7. PubMed ID: 3941399 [Abstract] [Full Text] [Related]
16. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage. Sun BL, Zhang SM, Xia ZL, Yang MF, Yuan H, Zhang J, Xiu RJ. Clin Hemorheol Microcirc; 2003 Jan 08; 29(3-4):337-44. PubMed ID: 14724359 [Abstract] [Full Text] [Related]
18. Pial arterial vasodilation by intravenous nimodipine in cats. Auer LM. Arzneimittelforschung; 1981 Jan 08; 31(9):1423-5. PubMed ID: 7197947 [Abstract] [Full Text] [Related]
19. Effects of 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation and metabolism in cats. Izumi Y, Isozumi K, Fukuuchi Y, Gotoh F. Arzneimittelforschung; 1989 Apr 08; 39(4):438-40. PubMed ID: 2502125 [Abstract] [Full Text] [Related]
20. The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists. McCalden TA, Nath RG, Thiele K. Stroke; 1984 Apr 08; 15(3):527-30. PubMed ID: 6427982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]